LENSAR, Inc. (LNSR) stock
LNSRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3023% below fair value
$4.64−0.21 (-4.33%)
Close on Nov 19, 2026Market cap $57.01MP/E –Yield –
Lensar operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Lensar's operating income for the twelve months ending Jun 30, 2026 was -$8.13M. For fiscal 2025 it was -$24.58M. The highest annual figure on record is -$10.67M in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$24.58M | – |
| FY2024 | Dec 31, 2024 | -$10.67M | – |
| FY2023 | Dec 31, 2023 | -$12.23M | – |
| FY2022 | Dec 31, 2022 | -$20.18M | – |
| FY2021 | Dec 31, 2021 | -$19.65M | – |
| FY2020 | Dec 31, 2020 | -$18.50M | – |
| FY2019 | Dec 31, 2019 | -$12.71M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.13M | – |
| Q1 FY2026 | Mar 31, 2026 | $2.24M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.92M | – |
| Q3 FY2025 | Sep 30, 2025 | -$7.58M | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.29M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.79M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.29M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.25M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.28M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.85M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.96M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.04M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.87M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.36M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.61M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.08M | – |
| Q2 FY2022 | Jun 30, 2022 | -$6.80M | – |
| Q1 FY2022 | Mar 31, 2022 | -$6.68M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.91M | – |
| Q3 FY2021 | Sep 30, 2021 | -$6.17M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.38M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.20M | – |
| Q4 FY2020 | Dec 31, 2020 | -$6.85M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.71M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.84M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.10M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.93M | – |
| Q3 FY2019 | Sep 30, 2019 | -$5.34M | – |
See a number that looks wrong?